Loading
Latest filing published 30 Mar 2024 for Biocon Limited, €32k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Akhilesh Nand in Biocon Limited. We count 7 filings; the first trade dates from 23 June 2021 and the latest from 28 March 2024.
The open-market record consists of 3 sales worth €178k, with no purchase. Besides market trades, the filings include 4 share grants. In 2024 alone, the filings show no purchases and 1 sale.
The record was last updated on 30 March 2024 with an open-market sale (€32k) in Biocon Limited. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations